Quantitative Lipidomic Analysis of Takotsubo Syndrome Patients' Serum
暂无分享,去创建一个
S. Ergün | G. Liebisch | C. Förster | S. Karnati | S. Shityakov | D. Kosanovic | M. Nagai | M. Höring | G. Guntas | Ranjithkumar Rajendran | Marcus Höring
[1] J. Borén,et al. Glucosylceramide synthase deficiency in the heart compromises β1-adrenergic receptor trafficking , 2021, European heart journal.
[2] N. Oda,et al. A mid‐ventricular variant of Takotsubo syndrome: was it triggered by insular cortex damage? , 2021, ESC heart failure.
[3] Christer S. Ejsing,et al. Accurate quantification of lipid species affected by isobaric overlap in Fourier-transform mass spectrometry , 2021, Journal of lipid research.
[4] Jianping Zhao,et al. Revealing the role of glycerophospholipid metabolism in asthma through plasma lipidomics. , 2020, Clinica chimica acta; international journal of clinical chemistry.
[5] Christer S. Ejsing,et al. Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures. , 2020, Journal of lipid research.
[6] C. Förster,et al. Right insular cortex atrophy in Takotsubo syndrome: a possible pathogenesis of increased sympathetic nervous system activity? , 2020, Clinical Research in Cardiology.
[7] V. Dolinsky,et al. The Cardiac Lipidome in Models of Cardiovascular Disease , 2020, Metabolites.
[8] N. Oda,et al. Happy heart syndrome: a case of Takotsubo syndrome with left internal carotid artery occlusion , 2020, Clinical Autonomic Research.
[9] S. Störk,et al. Increased Catecholamine Levels and Inflammatory Mediators Alter Barrier Properties of Brain Microvascular Endothelial Cells in vitro , 2020, Frontiers in Cardiovascular Medicine.
[10] L. Cowart,et al. Sphingolipid Mediators of Myocardial Pathology , 2019, Journal of lipid and atherosclerosis.
[11] G. Shui,et al. Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progression. , 2019, Journal of genetics and genomics = Yi chuan xue bao.
[12] Sen Li,et al. The metabolic change in serum lysoglycerophospholipids intervened by triterpenoid saponins from Kuding tea on hyperlipidemic mice. , 2019, Food & function.
[13] A. Henning,et al. Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy , 2019, Circulation.
[14] F. Parveen,et al. An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases , 2019, International journal of molecular sciences.
[15] Christer S. Ejsing,et al. Quantification of Cholesterol and Cholesteryl Ester by Direct Flow Injection High-Resolution Fourier Transform Mass Spectrometry Utilizing Species-Specific Response Factors. , 2019, Analytical chemistry.
[16] G. Horgan,et al. Characterization of the Myocardial Inflammatory Response in Acute Stress-Induced (Takotsubo) Cardiomyopathy , 2018, JACC. Basic to translational science.
[17] B. Spengler,et al. Quantitative lipidomic analysis of mouse lung during postnatal development by electrospray ionization tandem mass spectrometry , 2018, PloS one.
[18] Corey Giles,et al. Lipidomic Profiles of the Heart and Circulation in Response to Exercise versus Cardiac Pathology: A Resource of Potential Biomarkers and Drug Targets. , 2018, Cell reports.
[19] P. Meikle,et al. Lipidomics Reveals a Tissue-Specific Fingerprint , 2018, Front. Physiol..
[20] Jeroen J. Bax,et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology , 2018, European heart journal.
[21] Yusuf A. Hannun,et al. Sphingolipids and their metabolism in physiology and disease , 2017, Nature Reviews Molecular Cell Biology.
[22] F. Yan,et al. Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics , 2017, BMC Pulmonary Medicine.
[23] P. Tornvall,et al. Epidemiology, pathogenesis, and management of takotsubo syndrome , 2017, Clinical Autonomic Research.
[24] Wu Zhu,et al. Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis , 2017, GigaScience.
[25] Fei Shang,et al. Changes of myocardial lipidomics profiling in a rat model of diabetic cardiomyopathy using UPLC/Q-TOF/MS analysis , 2017, Diabetology & Metabolic Syndrome.
[26] F. Crea,et al. Pathophysiology of Takotsubo Syndrome , 2017, Circulation.
[27] G. Shui,et al. Sequestration of polyunsaturated fatty acids in membrane phospholipids of Caenorhabditis elegans dauer larva attenuates eicosanoid biosynthesis for prolonged survival , 2017, Redox biology.
[28] C. Sihlbom,et al. Anaesthetic‐induced cardioprotection in an experimental model of the Takotsubo syndrome – isoflurane vs. propofol , 2017, Acta anaesthesiologica Scandinavica.
[29] K. Hirano,et al. Energy Failure Hypothesis for Takotsubo Cardiomyopathy , 2017 .
[30] V. Salomaa,et al. Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[31] Xianlin Han,et al. Lipidomics for studying metabolism , 2016, Nature Reviews Endocrinology.
[32] K. Drosatos,et al. Lipid Use and Misuse by the Heart. , 2016, Circulation research.
[33] P. Camici,et al. Takotsubo cardiomyopathy and neurogenic stunned myocardium: similar albeit different. , 2016, European heart journal.
[34] N. Rose,et al. The varying faces of IL-6: From cardiac protection to cardiac failure. , 2015, Cytokine.
[35] A. Lyon,et al. Epidemiology and pathophysiology of Takotsubo syndrome , 2015, Nature Reviews Cardiology.
[36] G. Stone,et al. Mortality in takotsubo syndrome is similar to mortality in myocardial infarction - A report from the SWEDEHEART registry. , 2015, International journal of cardiology.
[37] Ji Li,et al. Metabolic shifts during aging and pathology. , 2015, Comprehensive Physiology.
[38] T. Yoshikawa. Takotsubo cardiomyopathy, a new concept of cardiomyopathy: clinical features and pathophysiology. , 2015, International journal of cardiology.
[39] Correction: Analysis of Lipid Experiments (ALEX): A Software Framework for Analysis of High-Resolution Shotgun Lipidomics Data , 2014, PLoS ONE.
[40] Ying-Yong Zhao,et al. Lipidomics applications for discovering biomarkers of diseases in clinical chemistry. , 2014, International review of cell and molecular biology.
[41] Kim Ekroos,et al. Analysis of Lipid Experiments (ALEX): A Software Framework for Analysis of High-Resolution Shotgun Lipidomics Data , 2013, PloS one.
[42] E. Omerovic,et al. Stress-induced cardiomyopathy (Takotsubo) – broken heart and mind? , 2013, Vascular health and risk management.
[43] J. Borén,et al. A mouse model reveals an important role for catecholamine‐induced lipotoxicity in the pathogenesis of stress‐induced cardiomyopathy , 2013, European journal of heart failure.
[44] S. Nekolla,et al. Simultaneous positron emission tomography/magnetic resonance imaging identifies sustained regional abnormalities in cardiac metabolism and function in stress-induced transient midventricular ballooning syndrome: a variant of Takotsubo cardiomyopathy. , 2012, Circulation.
[45] N. Peters,et al. High Levels of Circulating Epinephrine Trigger Apical Cardiodepression in a &bgr;2-Adrenergic Receptor/Gi–Dependent Manner: A New Model of Takotsubo Cardiomyopathy , 2012, Circulation.
[46] C. Weber,et al. Atherosclerosis: current pathogenesis and therapeutic options , 2011, Nature Medicine.
[47] G. Schmitz,et al. Plasmalogens the neglected regulatory and scavenging lipid species. , 2011, Chemistry and physics of lipids.
[48] J. Lafferty,et al. Serum lipoprotein levels in takotsubo cardiomyopathy vs. myocardial infarction , 2011, International archives of medicine.
[49] J. Lötjönen,et al. Serum Lipidomics Meets Cardiac Magnetic Resonance Imaging: Profiling of Subjects at Risk of Dilated Cardiomyopathy , 2011, PloS one.
[50] Eoin Fahy,et al. Lipidomics reveals a remarkable diversity of lipids in human plasma1[S] , 2010, Journal of Lipid Research.
[51] Kirill Degtyarenko,et al. ChEBI: An Open Bioinformatics and Cheminformatics Resource , 2009, Current protocols in bioinformatics.
[52] E. Blaak,et al. Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity , 2008, Physiology & Behavior.
[53] A. Shevchenko,et al. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. , 2008, Journal of lipid research.
[54] M. Hermansson,et al. Analysis of complex lipidomes , 2008 .
[55] S. Chauvie,et al. Reversible impairment of coronary flow reserve in takotsubo cardiomyopathy: A myocardial PET study , 2008, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[56] H. Schunkert,et al. Apical and midventricular transient left ventricular dysfunction syndrome (tako-tsubo cardiomyopathy): frequency, mechanisms, and prognosis. , 2007, Chest.
[57] Marko Sysi-Aho,et al. Acquired Obesity Is Associated with Changes in the Serum Lipidomic Profile Independent of Genetic Effects – A Monozygotic Twin Study , 2007, PloS one.
[58] M. Duchen,et al. IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes. , 2006, Cardiovascular research.
[59] Gerd Schmitz,et al. High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm. , 2004, Biochimica et biophysica acta.
[60] R. Murphy,et al. Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids , 2004, Journal of the American Society for Mass Spectrometry.
[61] Ronald J A Wanders,et al. Functions and biosynthesis of plasmalogens in health and disease. , 2004, Biochimica et biophysica acta.
[62] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[63] K. Nishioka,et al. Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo-like left ventricular dysfunction. , 2003, Journal of the American College of Cardiology.
[64] G. Schmitz,et al. High-throughput quantification of lysophosphatidylcholine by electrospray ionization tandem mass spectrometry. , 2002, Clinical chemistry.
[65] W. Liao,et al. Phosphatidylinositol 3-Kinase as a Mediator of TNF-Induced NF-κB Activation1 , 2000, The Journal of Immunology.
[66] G. Schmitz,et al. Quantitative measurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI-MS/MS). , 1999, Journal of lipid research.
[67] Y. Abiko,et al. Lysophosphatidylcholine: A Possible Modulator of Ischemic Injury in the Heart , 1998 .
[68] N. Nakajima,et al. Selective impairment of HCO3(-)-dependent pHi regulation by lysophosphatidylcholine in guinea pig ventricular myocardium. , 1998, Cardiovascular research.
[69] W. J. Dyer,et al. A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.